These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34688576)

  • 1. The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019-2020.
    Kuo CY; Tsai WC; Lee HF; Ho TS; Huang LM; Shen CF; Liu CC;
    J Microbiol Immunol Infect; 2022 Aug; 55(4):611-619. PubMed ID: 34688576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of macrolide resistance in pediatric
    Jiang TT; Sun L; Wang TY; Qi H; Tang H; Wang YC; Han Q; Shi XQ; Bi J; Jiao WW; Shen AD
    Front Cell Infect Microbiol; 2023; 13():1181402. PubMed ID: 37249975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
    Ding G; Zhang X; Vinturache A; van Rossum AMC; Yin Y; Zhang Y
    Eur J Pediatr; 2024 Jul; 183(7):3001-3011. PubMed ID: 38634891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA.
    Lanata MM; Wang H; Everhart K; Moore-Clingenpeel M; Ramilo O; Leber A
    Emerg Infect Dis; 2021 Jun; 27(6):1588-1597. PubMed ID: 34013867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.
    Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M
    BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
    Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
    J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.
    Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH
    BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.
    Li P; Wang W; Zhang X; Pan J; Gong L
    Sci Rep; 2024 Mar; 14(1):5632. PubMed ID: 38453960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
    Choi JH; Seong GM; Ko Y; Kim YR; Kim C
    Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015].
    Aguilera-Alonso D; López Ruiz R; Centeno Rubiano J; Morell García M; Valero García I; Ocete Mochón MD; Montesinos Sanchis E
    An Pediatr (Engl Ed); 2019 Jul; 91(1):21-29. PubMed ID: 30679135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.
    Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Kim Y; Kim S; Park C; Seo JH; Sol IS; Sung M; Song MS; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung EH; Chung HL; Choi SM; Choi YJ; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ;
    BMC Infect Dis; 2020 Feb; 20(1):132. PubMed ID: 32050912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
    Chen YC; Hsu WY; Chang TH
    Emerg Infect Dis; 2020 Jul; 26(7):1382-1391. PubMed ID: 32568052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycoplasma pneumoniae in pediatric patients: Do macrolide-resistance and/or delayed treatment matter?
    Yang TI; Chang TH; Lu CY; Chen JM; Lee PI; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2019 Apr; 52(2):329-335. PubMed ID: 30341022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.
    Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia.
    Tang M; Wang D; Tong X; Wu Y; Zhang J; Zhang L; Yin Y; Cao Q
    BMC Pediatr; 2021 Feb; 21(1):90. PubMed ID: 33607971
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wang X; Li M; Luo M; Luo Q; Kang L; Xie H; Wang Y; Yu X; Li A; Dong M; Huang F; Gong C
    Emerg Microbes Infect; 2022 Dec; 11(1):1508-1517. PubMed ID: 35582916
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
    Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
    BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: A retrospective study.
    Yen MH; Yan DC; Wang CJ; Tsao KC; Huang YC; Cheng SW; Chiu CH; Huang YC; Lin TY
    J Microbiol Immunol Infect; 2023 Jun; 56(3):634-640. PubMed ID: 36737359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan.
    Wu PS; Chang LY; Lin HC; Chi H; Hsieh YC; Huang YC; Liu CC; Huang YC; Huang LM
    Pediatr Pulmonol; 2013 Sep; 48(9):904-11. PubMed ID: 23169584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hara K; Hazama K; Watanabe T; Yamanaka T; Sasaki S; Furuyama H; Shibata M; Shida S; Ishizaka A; Tabata Y; Aoyagi H; Naito H; Yoshioka M; Horino A; Kenri T;
    PLoS One; 2017; 12(3):e0173635. PubMed ID: 28288170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.